You are here

IID-1.3 Data Details

Expand All

IID-1.3 Reduce new hepatitis B cases among persons aged 2 to 18 years

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

Data Source: 
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology, and Laboratory Services (CDC/CSELS)
Bridged-race Population Estimates; Centers for Disease Control and Prevention, National Center for Health Statistics and U.S. Census Bureau (CDC/NCHS and Census)
Changed Since the Healthy People 2020 Launch: 
Yes
Measure: 
per 100,000
Baseline (Year): 
0.1 (2007)
Target: 
0.0
Target-Setting Method: 
Total elimination
Target-Setting Method Justification: 
The target is based on the low baseline rate, the strong childhood immunization program infrastructure, and the Advisory Committee on Immunization Practices (ACIP) immunization policy statement that was updated in 2005 and that asserted the feasibility of eliminating hepatitis B virus transmission in this age group.
Numerator: 

Number of reported new symptomatic hepatitis B cases among persons aged 2 to 18 years reported in the past 12 months

Denominator: 

Total population aged 2-18 years in reporting states

Comparable Healthy People 2010 Objective: 
Adapted from HP2010 objective
Data Collection Frequency: 
Annual
Methodology Notes: 

    Data are rates per 100,000 population based on the number of symptomatic cases of acute hepatitis B reported to NNDSS. A case definition for new symptomatic cases of hepatitis B is available from CDC.

    In 1991, CDC published comprehensive strategies for eliminating transmission of hepatitis B within the United States. This strategy included universal childhood vaccination. With full implementation of this strategy, the number and rate of hepatitis B cases among persons aged 2 to 18 years should be eliminated. To obtain state-specific measures, local Viral Hepatitis Surveillance Program data are used to determine the number of symptomatic hepatitis B cases among persons aged 2 to 18 years occurring in the state in the past 12 months.

    FOR SINGLE DATA YEARS: Case rates are calculated based on the resident population of the United States for the data year involved. For census years (e.g. 2010), population counts enumerated as of April 1 are used. For all other years, populations estimates as of July 1 are used. Postcensal population estimates are used in rate calculations for years after a census year and match the data year vintage (e.g. July 1, 2011 resident population estimates from Vintage 2011 are used as the denominator for 2011 rates). Postcensal population estimates are used in rate calculations for the years between censuses (e.g. 1991-1999, 2001-2009). Race-specific population estimates for 1991 and later use bridged-race categories.

Changes Between HP2010 and HP2020: 
This objective differs from Healthy People 2010 objective 14-01d in that the measure was revised from a count to a rate per 100,000 population.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch: 
In 2014, Population Estimates was added as a data source to reflect the measure's population denominator. The data and target were not revised. In 2015, the denominator data source name was revised from Population Estimates to Bridged-Race Population Estimates for Census 2000 and 2010. The numerator data source, baseline estimate, target, and target-setting method remain unchanged.

References

Additional resources about the objective

  1. CDC. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part 1: Immunization of Infants, Children and Adolescents: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, December 23, 2005, Vol. 54(RR-16):1-39.
  2. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance.